FNY Investment Advisers’s Roivant Sciences ROIV Stock Holding History

FNY Investment Advisers’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Sell	10 -30	-75%	-$887	﹤0.01%	1027
2026 Q1	$1K	Sell	40 -20	-33%	-$514	﹤0.01%	722
2025 Q4	$1K	Sell	60 -9,522	-99%	-$188K	﹤0.01%	848
2025 Q3	$144K	Sell	9,582 -9,951	-51%	-$123K	0.05%	322
2025 Q2	$220K	Buy	19,533 +9,997	+105%	+$108K	0.09%	200
2025 Q1	$96K	Sell	9,536 -1,980	-17%	-$21.4K	0.06%	223
2024 Q4	$136K	Sell	11,516 -10	-0.1%	-$118	0.07%	235
2024 Q3	$133K	Buy	11,526 +1,306	+13%	+$14.9K	0.06%	206
2024 Q2	$108K	Buy	10,220 +2,720	+36%	+$29.8K	0.07%	171
2024 Q1	$79	Buy	7,500 +4,500	+150%	+$48.5K	0.05%	209
2023 Q4	$33K	Buy	+3,000	New	+$29.2K	0.04%	221

Other funds holding ROIV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

FNY Investment Advisers's ROIV Position: Q2 2026 in Review

FNY Investment Advisers reduced its Roivant Sciences (ROIV) stake by 75% in Q2 2026, selling an estimated $887 and leaving 10 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1027.

FNY Investment Advisers first reported a position in ROIV in Q4 2023 and has held it in 11 quarters since. The position peaked at $220K in Q2 2025. 256 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

FNY Investment Advisers held 10 shares of Roivant Sciences worth $0 as of Q2 2026.
FNY Investment Advisers sold 30 Roivant Sciences shares in Q2 2026, an estimated $887.
Roivant Sciences made up ﹤0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #1027 holding.
FNY Investment Advisers first reported a position in Roivant Sciences in Q4 2023 and has held it in 11 quarters since.
FNY Investment Advisers's Roivant Sciences position peaked at $220K in Q2 2025.
256 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.